Literature DB >> 35140134

Mucosa-Associated Invariant T Cell Hypersensitivity to Staphylococcus aureus Leukocidin ED and Its Modulation by Activation.

Caroline Boulouis1, Edwin Leeansyah1,2,3, Srikanth Mairpady Shambat1, Anna Norrby-Teglund1, Johan K Sandberg4.   

Abstract

Mucosa-associated invariant T (MAIT) cells recognize bacterial riboflavin metabolite Ags presented by MHC class Ib-related protein (MR1) and play important roles in immune control of microbes that synthesize riboflavin. This includes the pathobiont Staphylococcus aureus, which can also express a range of virulence factors, including the secreted toxin leukocidin ED (LukED). In this study, we found that human MAIT cells are hypersensitive to LukED-mediated lysis and lost on exposure to the toxin, leaving a T cell population devoid of MAIT cells. The cytolytic effect of LukED on MAIT cells was rapid and occurred at toxin concentrations lower than those required for toxicity against conventional T cells. Furthermore, this coincided with high MAIT cell expression of CCR5, and loss of these cells was efficiently inhibited by the CCR5 inhibitor maraviroc. Interestingly, exposure and preactivation of MAIT cells with IL-12 and IL-18, or activation via TCR triggering, partially protected from LukED toxicity. Furthermore, analysis of NK cells indicated that LukED targeted the mature cytotoxic CD57+ NK cell subset in a CCR5-independent manner. Overall, these results indicate that LukED efficiently eliminates immune cells that can respond rapidly to S. aureus in an innate fashion without the need for clonal expansion, and that MAIT cells are exceptionally vulnerable to this toxin. Thus, the findings support a model where LukED secretion may allow S. aureus to avoid recognition by the rapid cell-mediated responses mediated by MAIT cells and NK cells.
Copyright © 2022 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35140134      PMCID: PMC9012079          DOI: 10.4049/jimmunol.2100912

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  57 in total

1.  Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo.

Authors:  Francis Alonzo; Meredith A Benson; John Chen; Richard P Novick; Bo Shopsin; Victor J Torres
Journal:  Mol Microbiol       Date:  2011-12-20       Impact factor: 3.501

2.  Antimicrobial activity of mucosal-associated invariant T cells.

Authors:  Lionel Le Bourhis; Emmanuel Martin; Isabelle Péguillet; Amélie Guihot; Nathalie Froux; Maxime Coré; Eva Lévy; Mathilde Dusseaux; Vanina Meyssonnier; Virginie Premel; Charlotte Ngo; Béatrice Riteau; Livine Duban; Delphine Robert; Shouxiong Huang; Martin Rottman; Claire Soudais; Olivier Lantz
Journal:  Nat Immunol       Date:  2010-06-27       Impact factor: 25.606

3.  Identification of biologic agents to neutralize the bicomponent leukocidins of Staphylococcus aureus.

Authors:  Rita Chan; Peter T Buckley; Aidan O'Malley; William E Sause; Francis Alonzo; Ashira Lubkin; Kristina M Boguslawski; Angela Payne; Jeffrey Fernandez; William R Strohl; Brian Whitaker; Anthony Simon Lynch; Victor J Torres
Journal:  Sci Transl Med       Date:  2019-01-16       Impact factor: 17.956

4.  NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung.

Authors:  Cherrie-Lee Small; Sarah McCormick; Navkiran Gill; Kapilan Kugathasan; Michael Santosuosso; Nickett Donaldson; David E Heinrichs; Ali Ashkar; Zhou Xing
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

5.  Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection.

Authors:  Tamara Reyes-Robles; Francis Alonzo; Lina Kozhaya; D Borden Lacy; Derya Unutmaz; Victor J Torres
Journal:  Cell Host Microbe       Date:  2013-10-16       Impact factor: 21.023

Review 6.  MAIT Cells in Health and Disease.

Authors:  Nicholas M Provine; Paul Klenerman
Journal:  Annu Rev Immunol       Date:  2019-01-27       Impact factor: 28.527

7.  CCR5 is a receptor for Staphylococcus aureus leukotoxin ED.

Authors:  Francis Alonzo; Lina Kozhaya; Stephen A Rawlings; Tamara Reyes-Robles; Ashley L DuMont; David G Myszka; Nathaniel R Landau; Derya Unutmaz; Victor J Torres
Journal:  Nature       Date:  2012-12-12       Impact factor: 49.962

8.  MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression.

Authors:  Christopher R Shaler; Joshua Choi; Patrick T Rudak; Arash Memarnejadian; Peter A Szabo; Mauro E Tun-Abraham; Jamie Rossjohn; Alexandra J Corbett; James McCluskey; John K McCormick; Olivier Lantz; Roberto Hernandez-Alejandro; S M Mansour Haeryfar
Journal:  PLoS Biol       Date:  2017-06-20       Impact factor: 8.029

9.  TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions.

Authors:  Tianqi Leng; Hossain Delowar Akther; Carl-Philipp Hackstein; Kate Powell; Thomas King; Matthias Friedrich; Zoe Christoforidou; Sarah McCuaig; Mastura Neyazi; Carolina V Arancibia-Cárcamo; Joachim Hagel; Fiona Powrie; Raphael Sanches Peres; Val Millar; Daniel Ebner; Rajesh Lamichhane; James Ussher; Timothy S C Hinks; Emanuele Marchi; Chris Willberg; Paul Klenerman
Journal:  Cell Rep       Date:  2019-09-17       Impact factor: 9.995

10.  Human MAIT cell cytolytic effector proteins synergize to overcome carbapenem resistance in Escherichia coli.

Authors:  Caroline Boulouis; Wan Rong Sia; Muhammad Yaaseen Gulam; Jocelyn Qi Min Teo; Yi Tian Png; Thanh Kha Phan; Jeffrey Y W Mak; David P Fairlie; Ivan K H Poon; Tse Hsien Koh; Peter Bergman; Chwee Ming Lim; Lin-Fa Wang; Andrea Lay Hoon Kwa; Johan K Sandberg; Edwin Leeansyah
Journal:  PLoS Biol       Date:  2020-06-08       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.